Search

Your search keyword '"Nahor Haddish-Berhane"' showing total 5 results
Start Over Author "Nahor Haddish-Berhane" Journal journal of thoracic oncology
5 results on '"Nahor Haddish-Berhane"'

2. P76.73 MARIPOSA: Randomized Phase 3 Study of First-line Amivantamab + Lazertinib vs Osimertinib vs Lazertinib in EGFR-mutant NSCLC

Author

D. Pang, T. Sun, K. Patel, Nahor Haddish-Berhane, M. Martinez, Roland Elmar Knoblauch, S.M. Shreeve, A. Roshak, J. Karkera, R.B. Verheijen, Jinqiao Xie, and J.C. Curtin

Subjects
Pulmonary and Respiratory Medicine, Oncology, medicine.medical_specialty, business.industry, Internal medicine, First line, Mutant, medicine, Phases of clinical research, Osimertinib, business
Published
2021
Full Text
View/download PDF

3. P50.04 Amivantamab in Combination With Chemotherapy in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC)

Author

Ramaswamy Govindan, Byoung Chul Cho, Toyoaki Hida, Christine M. Bestvina, Misako Nagasaka, Catherine A. Shu, Nahor Haddish-Berhane, S-H.I. Ou, R.B. Verheijen, A. Bhattacharya, K. Goto, K. Park, T. Agrawal, Roland Elmar Knoblauch, Ronald B. Natale, Jorge Gomez, Jung-Gon Lee, and Chee Khoon Lee

Subjects
Pulmonary and Respiratory Medicine, Oncology, medicine.medical_specialty, Chemotherapy, P50, business.industry, medicine.medical_treatment, non-small cell lung cancer (NSCLC), medicine.disease, Internal medicine, medicine, In patient, business
Published
2021
Full Text
View/download PDF

4. P76.74 PAPILLON: Randomized Phase 3 Study of Amivantamab Plus Chemotherapy vs Chemotherapy Alone in EGFR Exon20ins NSCLC

Author

T. Agrawal, J.C. Curtin, J. Karkera, Jinqiao Xie, E. Artis, A. Bhattacharya, K. Patel, T. Gopen, A. Roshak, Roland Elmar Knoblauch, and Nahor Haddish-Berhane

Subjects
Pulmonary and Respiratory Medicine, Oncology, medicine.medical_specialty, Chemotherapy, business.industry, medicine.medical_treatment, Internal medicine, medicine, Phases of clinical research, business
Published
2021
Full Text
View/download PDF

5. OA10.06 A First-in-Human Phase 1 Trial of the EGFR-cMET Bispecific Antibody JNJ-61186372 in Patients with Advanced Non-Small Cell Lung Cancer (NSCLC)

Author

Matthew V. Lorenzi, M-J. Ahn, H.R. Kim, S.J. Lee, Roland Elmar Knoblauch, Z. Aguilar, Sylvie Laquerre, Byoung Chul Cho, S. Triantos, Nahor Haddish-Berhane, K. Park, Minsun Hong, M. Curtis, Dawn Millington, and S. Chaplan

Subjects
0301 basic medicine, Pulmonary and Respiratory Medicine, Bispecific antibody, business.industry, non-small cell lung cancer (NSCLC), First in human, medicine.disease, 03 medical and health sciences, 030104 developmental biology, 0302 clinical medicine, Oncology, 030220 oncology & carcinogenesis, Cancer research, Medicine, In patient, business
Published
2018
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results